X
BTC/USD
$ 56,730  -0.91%
BTC/EUR
€ 50,139  -0.88%
BTC/CNY
¥ 384,644  -0.62%
BTC/GBP
£ 42,608  -1.16%
BTC/RUB
₽ 4,113,800  -0.91%
BTC volume
$ 14.97B
Altcoin volume
$ 88.38B
Crypto market cap
$ 2.48T
    Huling presyo % 24 Mataas 24 Mababa 24 Dami # Salapi Market cap

Biocoin

BIO

$ 0.000439 0 % $ 0.000439 $ 0.000439 616.34M $ 270.50K
Biocoin

Biocoin BIO

Huling presyo
$ 0.000439
%
0 %
24 Mataas
$ 0.000439
24 Mababa
$ 0.000439
24 Dami
# Salapi
616.34M
Market cap
$ 270.50K
Biocoin Mga chart
Biocoin Mga pamilihan
Palitan Pares Huling presyo 24 Dami
Yobit BIO/BTC $ 0.000567   $ 0.00
Ranggo ng coin: #7784 
Algorithm: 
Mineable:No 
Platform ng token: 
all time high:$ 0.02350876 
Pinakamadaming supply: 
All time low:$ 0.00005764 
Circulating supply:616,341,120 
ICO Presyo: n/a 
Cointype: 
All time low:$ 0.00005764 
Circulating supply:616,341,120 
ICO ROI:n/a 
Petsa ng paglabas:  
Biocoin Mga feed sa social media
Latest News
01. Dec 2021 | Akolkar B 01. Dec 2021 | Guest
Fidelity Prepares to Launch Spot Bitcoin ETF In Canada, Grayscale Lashes Out At SEC CryptAxx Set to Launch 10,000 NFT Guitars on Ethereum
30. Nov 2021 | Akolkar B 27. Nov 2021 | Akolkar B
Jerome Powell’s Reappointment As Fed Chairman Can ‘Slow Crypto Down’ Says Mike Novogratz Cryptocurrency Market Enters Heavy Correction, It’s A Black Friday Sale for Investors
26. Nov 2021 | Akolkar B 25. Nov 2021 | Akolkar B
Shiba Inu Has More than A Million Users Now, SHIB Price Reverses from Downtrend Grayscale Sees A $1 Trillion Opportunity In Metaverse Industry, Here’s What It Means to the Crypto World
24. Nov 2021 | Akolkar B 23. Nov 2021 | Akolkar B
While Top Cryptocurrencies Trade Under Pressure, Gaming Tokens Rally Big Time Ripple CEO Says they Are Seeing Good Progress In the SEC Case, Expects Settlement By 2022

We will update this as soon as possible. If you like to help, you can contact us.

 
We use cookies for analytics, advertising and to improve our site. To find out more about our cookies, see our Privacy Policy. If you agree to our use of cookies, please continue to use our site or press the accept button. Learn more